TUBERCULOSIS

Recommendations

Info

:: TABLE A4.5 Treatment outcomes by TB case type, 2014 and treatment outcomes for MDR/RR-TB and XDR-TB cases, 2013 Table A4.5 Treatment outcomes by TB case type, 2014 and treatment outcomes for MDR/RR-TB and XDR-TB cases, 2013 New and relapse, 2014 cohort Previously treated, excluding relapse, 2014 cohort HIV-positive TB, 2014 cohort MDR/RR-TB, 2013 cohort XDR-TB, 2013 cohort Cohort (Number) Success (%) Cohort (Number) Success (%) Cohort (Number) Slovenia 142 77 2 50 0 Success (%) Cohort (Number) Success (%) Cohort (Number) Solomon Islands 345 91 1 0 0 0 0 Somalia 12 903 86 227 59 30 77 0 Success (%) South Africa 319 752 78 4 652 63 183 697 76 10 614 48 611 24 South Sudan 8 335 71 521 69 859 71 Spain 4 689 58 228 52 200 39 Sri Lanka 8 980 84 168 62 19 63 4 50 0 Sudan 5 769 82 73 64 2 Suriname 146 77 12 33 37 68 0 0 Swaziland 5 455 78 381 66 3 925 78 331 60 5 60 Sweden 610 87 31 84 8 75 2 50 Switzerland Syrian Arab Republic 3 390 70 95 69 2 100 0 Tajikistan 5 149 89 355 82 625 60 4 75 Thailand 58 774 80 1 433 63 6 451 67 The Former Yugoslav Republic of Macedonia 281 87 1 100 1 0 2 50 0 Timor-Leste 3 657 84 121 66 2 50 0 Togo* 2 415 88 162 76 16 56 0 Tokelau Tonga 13 100 0 0 0 0 Trinidad and Tobago 251 64 42 29 63 44 7 71 0 Tunisia 3 134 91 39 64 12 100 14 79 0 Turkey 12 933 87 192 50 41 66 228 65 3 33 Turkmenistan Turks and Caicos Islands 1 0 0 1 0 0 0 Tuvalu 15 47 0 0 0 0 Uganda 43 628 75 2 438 67 16 670 73 214 73 0 Ukraine 22 294 72 5 269 66 6 104 35 7 633 39 United Arab Emirates 40 80 1 0 3 0 0 0 United Kingdom of Great Britain and Northern Ireland 6 512 81 450 72 77 65 3 33 United Republic of Tanzania 61 573 90 1 578 81 20 658 87 92 68 0 United States of America 8 237 85 397 79 467 80 39 79 1 100 Uruguay 843 75 26 88 130 51 1 100 0 US Virgin Islands Uzbekistan 16 328 87 3 947 81 2 647 53 Vanuatu 39 87 1 100 0 0 0 Venezuela (Bolivarian Republic of) 6 353 80 223 73 482 79 19 53 4 50 Viet Nam 100 349 91 1 738 76 1 519 75 959 69 Wallis and Futuna Islands* 0 0 0 0 2 100 West Bank and Gaza Strip 43 91 0 0 0 0 Yemen 9 437 86 65 66 9 67 Zambia 37 930 85 4 786 80 58 33 0 Zimbabwe* 29 653 81 2 363 51 19 290 68 351 59 WHO regions African Region 1 274 882 81 40 347 72 328 245 77 14 553 54 630 24 Region of the Americas 197 119 76 14 487 48 16 819 56 2 935 55 91 53 Eastern Mediterranean Region 438 187 91 10 995 79 404 53 1 950 68 67 30 European Region 216 485 76 22 429 63 7 923 41 42 486 52 2 761 27 South-East Asia Region 2 469 890 79 95 599 68 65 183 74 23 725 49 405 33 Western Pacific Region 1 277 110 92 19 062 80 5 700 72 6 512 57 282 37 Global 5 873 673 83 202 919 69 424 274 75 92 161 52 4 236 28 a Relapses included in the previously treated cohort. * Relapses included in the previously treated cohort. Data for all years can be downloaded from www.who.int/tb/data GLOBAL <strong>TUBERCULOSIS</strong> REPORT 2016 :: 201
ISBN 9 789241 565394 Ending TB by 2030 www.who.int/tb/data
Page 1 and 2:
GLOBAL REPORT TUBERCULOSIS 2016
Page 3 and 4:
WHO Library Cataloguing-in-Publicat
Page 5 and 6:
:: Abbreviations aDSM AE AIDS ART A
Page 7 and 8:
The principal source of financial s
Page 9:
Zhumagali Ismailov, Sarah Jackson,
Page 12 and 13:
:: Executive Summary Background The
Page 14 and 15:
TB prevention services South Africa
Page 16 and 17:
Chapter 1 :: Introduction Tuberculo
Page 18 and 19:
:: Box 2.1 The Sustainable Developm
Page 20 and 21:
:: Box 2.3 The End TB Strategy at a
Page 22 and 23:
:: TABLE 2.1 Top 10 indicators (not
Page 24 and 25:
TABLE 2.2 :: The three TB high-burd
Page 26 and 27:
Chapter 3 :: TB disease burden :: K
Page 28 and 29:
:: Box 3.1 The WHO Global Task Forc
Page 30 and 31:
:: Box 3.2 Updates to estimates of
Page 32 and 33:
:: Box 3.3 Updated and interim esti
Page 34 and 35:
:: FIG. 3.1 Strengthening national
Page 36 and 37:
:: TABLE 3.2 Estimated epidemiologi
Page 38 and 39:
:: FIG. 3.3 Estimated TB incidence
Page 40 and 41:
:: FIG. 3.5 Global trends in the es
Page 42 and 43:
:: FIG. 3.8 Trends in estimated TB
Page 44 and 45:
:: FIG. 3.10a Top causes of death w
Page 46 and 47:
:: FIG. 3.14 Trends in estimated TB
Page 48 and 49:
:: FIG. 3.16 Data sources available
Page 50 and 51:
:: TABLE 3.5 Estimated incidence of
Page 52 and 53:
:: FIG. 3.20 Estimated incidence of
Page 54 and 55:
:: FIG. 3.22 Global progress in imp
Page 56 and 57:
:: TABLE 3.6 Number of TB cases fou
Page 58 and 59:
:: TABLE 3.7 HIV-negative and HIV-p
Page 60 and 61:
:: FIG. 3.29a The prevalence:notifi
Page 62 and 63:
:: FIG. 3.31b The average CFR by st
Page 64 and 65:
SIM and SINAN case-based databases,
Page 66 and 67:
Prompt and accurate diagnosis of tu
Page 68 and 69:
:: FIG. 4.2 New and relapse TB case
Page 70 and 71:
:: FIG. 4.5 Percentage of new and r
Page 72 and 73:
:: FIG. 4.8 Global numbers of notif
Page 74 and 75:
:: TABLE 4.4 National guidance in p
Page 76 and 77:
:: FIG. 4.9 Percentage of bacteriol
Page 78 and 79:
:: FIG. 4.12 Number of MDR/RR-TB ca
Page 80 and 81:
:: FIG. 4.14 Case notification rate
Page 82 and 83:
:: FIG. 4.16a The ten countries wit
Page 84 and 85:
:: Box 4.5 Community contributions
Page 86 and 87:
:: FIG. 4.18 Estimated ART treatmen
Page 88 and 89:
issued in March 2013 and updated in
Page 90 and 91:
:: FIG. 4.22 Treatment outcomes for
Page 92 and 93:
:: Box 4.6 Active TB drug-safety mo
Page 94 and 95:
Prevention of new infections of Myc
Page 96 and 97:
:: TABLE 5.2 TB preventive treatmen
Page 98 and 99:
:: TABLE 5.3 Provision of TB preven
Page 100 and 101:
:: FIG. 5.5 Coverage of BCG vaccina
Page 102 and 103:
This chapter aims to provide a tube
Page 104 and 105:
:: FIG. 6.2 Government spending on
Page 106 and 107:
:: Box 6.1 Implications for TB of e
Page 108 and 109:
:: Box 6.2 Innovations in engaging
Page 110 and 111:
:: Box 6.4 Reforming systems to exp
Page 112 and 113:
:: TABLE 6.1 TB patient social supp
Page 114 and 115:
:: FIG. 6.5 Surveys of costs faced
Page 116 and 117:
:: TABLE 6.3 Status of selected SDG
Page 118 and 119:
Continue current trend (base case s
Page 120 and 121:
can provide insights into progress
Page 122 and 123:
lion, most (US$ 4.4 billion, 67%) i
Page 124 and 125:
:: Box 3.2 Updates to estimates of
Page 126 and 127:
:: FIG. 7.5 Funding for NTP budgets
Page 128 and 129:
:: Box 7.2 International donor fund
Page 130 and 131:
:: FIG. 7.6 Reported funding gaps f
Page 132 and 133:
:: Box 7.3 Methods used to estimate
Page 134 and 135:
:: Box 8.1 WHO’s Global Action Fr
Page 136 and 137:
is critical to allow for the time-s
Page 138 and 139:
:: FIG. 8.2 The global development
Page 140 and 141:
:: FIG. 8.3 The development pipelin
Page 142:
Annex 1 Access to the WHO global TB
Page 145 and 146:
A data dictionary that defines each
Page 147:
Annex 2 Country profiles :: FOR 30
Page 150 and 151:
Bangladesh population 2015 :: 161 m
Page 152 and 153:
China population 2015 :: 1 376 mill
Page 154 and 155:
Democratic Republic of the Congo po
Page 156 and 157:
India population 2015 :: 1 311 mill
Page 158 and 159:
Kenya population 2015 :: 46 million
Page 160 and 161: Myanmar population 2015 :: 54 milli
Page 162 and 163: Pakistan population 2015 :: 189 mil
Page 164 and 165: Russian Federation population 2015
Page 166 and 167: Thailand population 2015 :: 68 mill
Page 168: Viet Nam population 2015 :: 93 mill
Page 171 and 172: Central African Republic population
Page 173 and 174: Lesotho population 2015 :: 2.1 mill
Page 175 and 176: Namibia population 2015 :: 2.5 mill
Page 177 and 178: Sierra Leone population 2015 :: 6.5
Page 179 and 180: Zimbabwe population 2015 :: 16 mill
Page 182 and 183: WHO African Region WHO MEMBER STATE
Page 184 and 185: WHO Eastern Mediterranean Region WH
Page 186 and 187: WHO South-East Asia Region WHO MEMB
Page 188: Annex 4 TB burden estimates, notifi
Page 191 and 192: :: TABLE A4.1 TB incidence estimate
Page 193 and 194: :: TABLE A4.1 Table TB incidence A4
Page 195 and 196: :: Table TABLE A4.2 A4.2 Estimates
Page 197 and 198: Table :: TABLE A4.2 A4.2 Estimates
Page 199 and 200: :: TABLE A4.3 Measured percentage o
Page 201 and 202: :: TABLE A4.3 Measured Table A4.3 p
Page 203 and 204: :: TABLE A4.4 TB case notifications
Page 205 and 206: :: TABLE A4.4 TB case notifications
Page 207 and 208: :: TABLE A4.5 Treatment outcomes by
Page 209: :: TABLE A4.5 Treatment outcomes by
show all

TUBERCULOSIS

Create successful ePaper yourself

Delete template?

Save as template?